SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-07-13
👔
Caris Life Sciences, Inc.
@CAI_InsiderForm 4 Filing: HALBERT JON Buys $990,080 of $CAI
INSIDER PURCHASE
⚡ MATERIALITY: 6/10
corporate issuer
Caris Life Sciences, Inc.
Ticker: $CAI
Transaction Value
$990,080
Price/Share: $14.56
transaction date
2026-05-15
Shares: 68,000
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, HALBERT JON, holds the title of Director at Caris Life Sciences, Inc..
On 2026-05-15, the insider transacted 68,000 shares.The shares were transacted at a weighted average price of $14.56 per share, resulting in a total market-relevant value of $990,080.
Executive Summary Summary
HALBERT JON (Director) bought $990K of $CAI
Post-Transaction Position: 704,598 shares
SEC Accession No: 0001189394-26-000005 (CIK: 1189394)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.